15 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Tearaway Introducer Sheath, MicroSlide Tearaway Introducer

FDA 510(k)
FDA Class 2 ·Cardiovascular

LEONE SPA

FDA UDI
LEONE SPA·08033707015253·CALIBRA 1ST MOL BANDS W/G8325-03 n.UL 33

IMMULITE/IMMULITE 1000 TURBO INTACT PTH

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

ES TROCHANTERIC NAIL, LEFT AND RIGHT, 10MM

FDA 510(k)
FDA Class 2 ·Orthopedic

BAXANO IO-FLEX SYSTEM

FDA Adverse Event
Other ·BAXANO, INC.·Product code HAE·July 2, 2012

BAXANO IO-FLEX SYSTEM

FDA Adverse Event
Other ·BAXANO, INC.·Product code HAE·July 2, 2012

BAXANO IO-FLEX SYSTEM

FDA Adverse Event
Other ·BAXANO, INC.·Product code HAE·July 2, 2012

GMK-SPHERE FEMORAL COMPONENT SPHERE CEMENTED SIZE 4

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code JWH·April 22, 2016

CAPSUREFIXNOVUS

FDA Adverse Event
Injury ·MPRI·Product code DTB·June 8, 2013

QUADRA ASSURA CRT-D, DF-4 CONNECTOR

FDA Adverse Event
Malfunction ·ST. JUDE MEDICAL, INC., CRMD·Product code NIK·October 8, 2014

7900

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS GMBH·Product code JAA·June 21, 2011

FUSION 8MM-40CM UNSUPP PERIPHERAL GRAFT

FDA Adverse Event
Malfunction ·MAQUET CV·Product code DSY·February 8, 2017

ELEKTA LIMITED Elekta Synergy, REF MRT 8501, MRT 8511; Medical Charged-Particle Radiation Therapy System Accelerator, Linear

FDA Enforcement
Class II ·Ongoing·Elekta, Inc.·December 13, 2023

IGuide System, software versions: 2.2.0, 2.2.1, 2.2.2 Product Usage: Linear Accelerator. The intended use of the device is the control of accurate patient positioning with assistance of a 30 Tracking System in a radiotherapy environment.

FDA Enforcement
Class II ·Terminated·Medical Intelligence Medizintechnik Gmbh·July 31, 2019

CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024